Fingerprint
Dive into the research topics of 'The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis
Madeline Kelly, Arseniy Lavrov, Luis Garcia-Gancedo, Jim Parr, Robert Hart, Theresa Chiwera, Christopher E Shaw, Ammar Al-Chalabi, Rachael Marsden, Martin R Turner, Kevin Talbot
- Clinical Translational Medicine, Future Pipeline Discovery, GSK R&D, Hertfordshire, UK.
- Clinical Translational Medicine, Future Pipeline Discovery, GSK R&D, Middlesex, UK.
- Advanced Biostatistics and Data Analytics CoE, GSK, Hertfordshire, UK.
- McLaren Applied Technologies, Surrey, UK.
- Maurice Wohl Clinical Neuroscience Institute
- Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9RX, UK. [email protected].
- Department of Neurology, King's College Hospital, London, UK
- University of Oxford
Research output: Contribution to journal › Article › peer-review
15
Citations
(Scopus)